Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Detalhes bibliográficos
Principais autores:	Clerico, M, Faggiano, F, Palace, J, Rice, G, Tintore, M, Durelli, L
Formato:	Conference item
Publicado em:	2005

Registros relacionados